Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen

Brown, K; Thomas, D; McKenney, K; Reeder, M; Simonson, RB; Bicer, C; Nettles, RE; Crauwels, H

Brown, K (reprint author), AAHIVE, 1125 Trenton Harbourton Rd,B3, Titusville, NJ 08560 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019; 8 (4): 541

Abstract

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is an oral once-daily single-tablet regimen for the treatment of human immunodefi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索